TY  - GEN
AU  - Wirtz,Paul W
AU  - Titulaer,Maarten J
AU  - Gerven,Joop Ma van
AU  - Verschuuren,Jan J
TI  - 3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome
SN  - 1744-8409
PY  - 2011///0524
KW  - 4-Aminopyridine
KW  - adverse effects
KW  - Action Potentials
KW  - drug effects
KW  - Amifampridine
KW  - Calcium Channels
KW  - metabolism
KW  - Cholinergic Agents
KW  - Clinical Protocols
KW  - Epilepsy
KW  - etiology
KW  - Humans
KW  - Lambert-Eaton Myasthenic Syndrome
KW  - drug therapy
KW  - Muscles
KW  - Paresthesia
KW  - Presynaptic Terminals
KW  - Randomized Controlled Trials as Topic
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1586/eci.10.57
ER  -